Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10247738 Diagnosing and treating Alzheimers disease

Patent 10247738 was granted and assigned to Dignity Health on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jiong Shi0

Peng Cheng Han0

Date of Patent

April 2, 2019

0

Patent Application Number

159626910

Date Filed

April 25, 2018

0

Patent Citations Received

US Patent 10968268 Humanized anti-PACAP antibodies

US Patent 11938185 Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies

0

US Patent 11352409 Anti-PACAP antibodies and uses thereof

0

US Patent 10954285 Humanized anti-PACAP antibodies

US Patent 10975135 Humanized anti-PACAP antibodies

Patent Primary Examiner

0

Patent abstract

Described herein are methods, systems and compositions for the diagnosis, prognosis and treatment of dementia and Alzheimer's disease. Also described are methods, systems and compositions to distinguish between Alzheimer's disease and Parkinson's disease. In various embodiments levels of PACAP and/or SIRT3 are analyzed for the diagnosis, prognosis and treatment of dementia and Alzheimer's disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10247738 Diagnosing and treating Alzheimers disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.